These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36056076)

  • 21. Preclinical Evaluation of
    Prignon A; Provost C; Alshoukr F; Wendum D; Couvelard A; Barbet J; Forgez P; Talbot JN; Gruaz-Guyon A
    Mol Pharm; 2019 Jun; 16(6):2776-2784. PubMed ID: 31013092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
    Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
    J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [99mTc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results.
    Maina T; Nikolopoulou A; Stathopoulou E; Galanis AS; Cordopatis P; Nock BA
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1804-14. PubMed ID: 17594090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and evaluation of a (18)F-labeled diarylpyrazole glycoconjugate for the imaging of NTS1-positive tumors.
    Lang C; Maschauer S; Hübner H; Gmeiner P; Prante O
    J Med Chem; 2013 Nov; 56(22):9361-5. PubMed ID: 24160350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and Evaluation of 64Cu-DOTA-NT-Cy5.5 as a Dual-Modality PET/Fluorescence Probe to Image Neurotensin Receptor-Positive Tumor.
    Deng H; Wang H; Wang M; Li Z; Wu Z
    Mol Pharm; 2015 Aug; 12(8):3054-61. PubMed ID: 26162008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use.
    He T; Wang M; Wang H; Tan H; Tang Y; Smith E; Wu Z; Liao W; Hu S; Li Z
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2199-2207. PubMed ID: 31264168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of a (68)ga-labeled peptoid-Peptide hybrid for imaging of neurotensin receptor expression in vivo.
    Maschauer S; Einsiedel J; Hocke C; Hübner H; Kuwert T; Gmeiner P; Prante O
    ACS Med Chem Lett; 2010 Aug; 1(5):224-8. PubMed ID: 24900199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence of
    Marenco M; Lodola L; Persico MG; Frangipane V; Facoetti A; Aprile C; Hodolič M
    Curr Pharm Biotechnol; 2018; 19(9):754-759. PubMed ID: 30160211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
    Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
    J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
    de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and nts2 receptors of mammals.
    Belmeguenai A; Vaudry H; Leprince J; Vivet B; Cavelier F; Martinez J; Louiset E
    Neuroendocrinology; 2000 Dec; 72(6):379-91. PubMed ID: 11146421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modifications at Arg and Ile Give Neurotensin(8-13) Derivatives with High Stability and Retained NTS
    Schindler L; Bernhardt G; Keller M
    ACS Med Chem Lett; 2019 Jun; 10(6):960-965. PubMed ID: 31223455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential use of radiolabelled neurotensin in PET imaging and therapy of patients with pancreatic cancer.
    Hodolic M; Ambrosini V; Fanti S
    Nucl Med Commun; 2020 May; 41(5):411-415. PubMed ID: 32168264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.
    Keller M; Kuhn KK; Einsiedel J; Hübner H; Biselli S; Mollereau C; Wifling D; Svobodová J; Bernhardt G; Cabrele C; Vanderheyden PM; Gmeiner P; Buschauer A
    J Med Chem; 2016 Mar; 59(5):1925-45. PubMed ID: 26824643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours.
    García-Garayoa E; Bläuenstein P; Blanc A; Maes V; Tourwé D; Schubiger PA
    Eur J Nucl Med Mol Imaging; 2009 Jan; 36(1):37-47. PubMed ID: 18690434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Label-free cell phenotypic profiling and pathway deconvolution of neurotensin receptor-1.
    Hou T; Shi L; Wang J; Wei L; Qu L; Zhang X; Liang X
    Pharmacol Res; 2016 Jun; 108():39-45. PubMed ID: 27117668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topography of the neurotensin (NT)(8-9) binding site of human NT receptor-1 probed with NT(8-13) analogs.
    Lundquist JT; Büllesbach EE; Golden PL; Dix TA
    J Pept Res; 2002 Feb; 59(2):55-61. PubMed ID: 11906607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Syntheses, receptor bindings, in vitro and in vivo stabilities and biodistributions of DOTA-neurotensin(8-13) derivatives containing β-amino acid residues - a lesson about the importance of animal experiments.
    Sparr C; Purkayastha N; Yoshinari T; Seebach D; Maschauer S; Prante O; Hübner H; Gmeiner P; Kolesinska B; Cescato R; Waser B; Reubi JC
    Chem Biodivers; 2013 Dec; 10(12):2101-21. PubMed ID: 24327436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotensin receptor 1 facilitates intracellular and transepithelial delivery of macromolecules.
    Bird JL; Simpson R; Vllasaliu D; Goddard AD
    Eur J Pharm Biopharm; 2017 Oct; 119():300-309. PubMed ID: 28690201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NTS1 and NTS2 mediate analgesia following neurotensin analog treatment in a mouse model for visceral pain.
    Smith KE; Boules M; Williams K; Richelson E
    Behav Brain Res; 2012 Jun; 232(1):93-7. PubMed ID: 22504145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.